| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology 2000; 39: 122-132
© 2000 British Society for Rheumatology
Review |
The links between joint damage and disability in rheumatoid arthritis
Clinical and Academic Rheumatology, Kings College Hospital (Dulwich), London,
1 Economists Advisory Group Ltd, 105 Victoria Street, London, UK,
2 Rheumatism Foundation Hospital, 18120 Fin, Heinola, Finland and
3 F. Hoffmann-La Roche Ltd, Basel, Switzerland
Objective. The characteristic joint damage and disability of rheumatoid arthritis (RA) increase slowly over 10–20 yr. Although it is generally believed that persisting inflammatory synovitis causes joint damage and subsequent disability, the strength of their relationship has not been systematically evaluated. This review describes their progression and interrelationship in treated RA.
Methods. MEDLINE and Current Contents databases were searched for the combined terms of rheumatoid arthritis AND X-rays, Health Assessment Questionnaire, slow-acting anti-rheumatic drugs and all identifiable synonyms. This search identified 1303 articles and from these we evaluated in detail 23 reports on the progression of joint damage, 12 reports on the progression of disability and 25 reports dealing with their interrelationship. Additional information was obtained from four data sets comprising 725 RA patients studied cross-sectionally and 33–126 cases followed prospectively for 1–5 yr. X-ray damage was primarily assessed by Larsen and Sharp indices, and disability by the Health Assessment Questionnaire (HAQ).
Results. Joint damage and disability both increase throughout the duration of RA. Although disability (HAQ score) is correlated with disease duration (correlation coefficients between 0.27 and 0.30), the link between X-ray damage and disability is stronger (correlation coefficients between 0.30 and 0.70). In the earliest phases of RA, X-ray damage and HAQ scores are not related. By 5–8 yr, there are significant correlations with correlation coefficients between 0.30 and 0.50. In late RA (>8 yr), most studies show highly significant correlations between 0.30 and 0.70.
Conclusions. Joint damage progresses constantly over the first 20 yr of RA. It accounts for ~25% of disability in established RA. The link between damage and disability is strongest in late (>8 yr) RA. However, avoiding or reducing joint damage in both early and established/late RA is likely to maintain function.
KEY WORDS: Joint damage, Disability, Rheumatoid arthritis.
5 Correspondence to: D. L. Scott, Clinical and Academic Rheumatology, Kings College Hospital (Dulwich), East Dulwich Grove, London SE22 8PT, UK.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Finckh, N. Bansback, C. A. Marra, A. H. Anis, K. Michaud, S. Lubin, M. White, S. Sizto, and M. H. Liang Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents: A Cost-Effectiveness Analysis Ann Intern Med, November 3, 2009; 151(9): 612 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Vastesaeger, S. Xu, D. Aletaha, E. W. St Clair, and J. S. Smolen A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis Rheumatology, September 1, 2009; 48(9): 1114 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Keystone, P Emery, C G Peterfy, P P Tak, S Cohen, M C Genovese, M Dougados, G R Burmester, M Greenwald, T K Kvien, et al. Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies Ann Rheum Dis, February 1, 2009; 68(2): 216 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Prouse, J. Reeback, N. Betteridge, and on behalf of ARMA Board of Trustees Comment on: Is it ever appropriate to discharge patients with rheumatoid arthritis? Rheumatology, May 1, 2008; 47(5): 741 - 741. [Full Text] [PDF]
|
|
|
|
|
|
D. L. Scott and D. P. M. Symmons The role of specialists in managing established rheumatoid arthritis Rheumatology, March 1, 2008; 47(3): 237 - 238. [Full Text] [PDF]
|
|
|
|
|
|
W. J. Taylor and P. S. Helliwell Psoriatic arthritis is a joint-damaging disease a call for action! Rheumatology, December 1, 2007; 46(12): 1747 - 1748. [Full Text] [PDF]
|
|
|
|
|
|
M. M Ward Interpreting measurements of physical function in clinical trials Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii32 - iii34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Hyrich, K. D. Watson, A. J. Silman, D. P. M. Symmons, and The BSR Biologics Register Predictors of response to anti-TNF-{alpha} therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register Rheumatology, December 1, 2006; 45(12): 1558 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Zheng, E Robinson, S Yeoman, N Stewart, J Crabbe, J Rouse, and F M McQueen MRI bone oedema predicts eight year tendon function at the wrist but not the requirement for orthopaedic surgery in rheumatoid arthritis Ann Rheum Dis, May 1, 2006; 65(5): 607 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Plant, M. M. O'Sullivan, P. A. Lewis, J. P. Camilleri, E. C. Coles, and J. D. Jessop What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time? Rheumatology, September 1, 2005; 44(9): 1181 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. M. Verstappen, A. Boonen, J. W. J. Bijlsma, E. Buskens, H. Verkleij, Y. Schenk, G. A. van Albada-Kuipers, D. M. Hofman, J. W. G. Jacobson, and on behalf of the Utrecht Rheumatoid Arthritis Coho Working status among Dutch patients with rheumatoid arthritis: work disability and working conditions Rheumatology, February 1, 2005; 44(2): 202 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kitaura, M. S. Sands, K. Aya, P. Zhou, T. Hirayama, B. Uthgenannt, S. Wei, S. Takeshita, D. V. Novack, M. J. Silva, et al. Marrow Stromal Cells and Osteoclast Precursors Differentially Contribute to TNF-{alpha}-Induced Osteoclastogenesis In Vivo J. Immunol., October 15, 2004; 173(8): 4838 - 4846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Forslind, M Ahlmen, K Eberhardt, I Hafstrom, and B Svensson Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP) Ann Rheum Dis, September 1, 2004; 63(9): 1090 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Cohen, V. Strand, D. Aguilar, and J. J. Ofman Patient- versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy Rheumatology, June 1, 2004; 43(6): 704 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Adams, J Burridge, M Mullee, A Hammond, and C Cooper Correlation between upper limb functional ability and structural hand impairment in an early rheumatoid population Clinical Rehabilitation, April 1, 2004; 18(4): 405 - 413. [Abstract] [PDF]
|
|
|
|
|
|
A. Brennan, N. Bansback, A. Reynolds, and P. Conway Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK Rheumatology, January 1, 2004; 43(1): 62 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P A Ory Interpreting radiographic data in rheumatoid arthritis Ann Rheum Dis, July 1, 2003; 62(7): 597 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Wick, P Peloschek, K Bogl, W Graninger, J S Smolen, and F Kainberger The "X-Ray RheumaCoach" software: a novel tool for enhancing the efficacy and accelerating radiological quantification in rheumatoid arthritis Ann Rheum Dis, June 1, 2003; 62(6): 579 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Smolen, F. C. Breedveld, M. H. Schiff, J. R. Kalden, P. Emery, G. Eberl, P. L. van Riel, and P. Tugwell A simplified disease activity index for rheumatoid arthritis for use in clinical practice Rheumatology, February 1, 2003; 42(2): 244 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V Strand, R Landewe, and D van der Heijde Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis Ann Rheum Dis, November 1, 2002; 61(90002): ii64 - 66. [Full Text] [PDF]
|
|
|
|
|
|
S. B. Abramson and A. Amin Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage Rheumatology, September 1, 2002; 41(9): 972 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Scott and V. Strand The effects of disease-modifying anti-rheumatic drugs on the Health Assessment Questionnaire score. Lessons from the leflunomide clinical trials database Rheumatology, August 1, 2002; 41(8): 899 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M H Weisman Newly diagnosed rheumatoid arthritis Ann Rheum Dis, April 1, 2002; 61(4): 287 - 289. [Full Text] [PDF]
|
|
|
|
|
|
P Emery, F C Breedveld, M Dougados, J R Kalden, M H Schiff, and J S Smolen Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide Ann Rheum Dis, April 1, 2002; 61(4): 290 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Kvien Epidemiology of disability in rheumatoid arthritis Rheumatology, February 1, 2002; 41(2): 121 - 123. [Full Text] [PDF]
|
|
|
|
|
|
D van der Heijde Radiographic progression in rheumatoid arthritis: Does it reflect outcome? Does it reflect treatment? Ann Rheum Dis, November 1, 2001; 60(90003): iii47 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L M A Jansen, I E van der Horst-Bruinsma, D van Schaardenburg, P D Bezemer, and B A C Dijkmans Predictors of radiographic joint damage in patients with early rheumatoid arthritis Ann Rheum Dis, October 1, 2001; 60(10): 924 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F M McQueen, N Benton, J Crabbe, E Robinson, S Yeoman, L McLean, and N Stewart What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease Ann Rheum Dis, September 1, 2001; 60(9): 859 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nordahl, P. Alstergren, S. Eliasson, and S. Kopp Radiographic signs of bone destruction in the arthritic temporomandibular joint with special reference to markers of disease activity. A longitudinal study Rheumatology, June 1, 2001; 40(6): 691 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rau, G. Herborn, and H. Fenner Links between joint damage and disability Rheumatology, December 1, 2000; 39(12): 1434 - 1435. [Full Text] [PDF]
|
|
|
|
|
|
J. Kempeni Update on D2E7: a fully human anti-tumour necrosis factor alpha monoclonal antibody Ann Rheum Dis, November 1, 2000; 59(90001): i44 - 45. [Full Text] [PDF]
|
|